| 51 |
10367743 | Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide. | 1999 |
1 |
| 52 |
10381626 | Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. | 1999 Apr |
1 |
| 53 |
10554032 | Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. | 1999 Nov 1 |
1 |
| 54 |
10732782 | Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas. | 1999 Mar |
1 |
| 55 |
9713486 | Complex response of breast epithelial cell lines to topoisomerase inhibitors. | 1998 Jul-Aug |
1 |
| 56 |
9306577 | Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide. | 1997 |
1 |
| 57 |
9494534 | Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. | 1997 Nov-Dec |
1 |
| 58 |
8620501 | Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. | 1996 Apr 15 |
1 |
| 59 |
8798452 | Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. | 1996 Sep 13 |
1 |
| 60 |
8943258 | Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death. | 1996 Dec 13 |
1 |